Zheng Quan Zhi Xing·2025-09-01 00:08Group 1 - Freshwater Capital recently conducted research on three listed companies, including Mindray Medical, Meichang Co., and Crystal Optoelectronics [1] - Mindray Medical launched the world's first clinically implemented critical care large model, named Qiyuan, and established an animal healthcare subsidiary [1] - In the medical imaging sector, Mindray's "Ruiying Cloud++" has partnered with DeepSeek to officially release the "Ruiying·AI+" solution [1] Group 2 - Meichang Co. reported a 12% overall cost reduction in Q2, with tungsten wire mother line costs decreasing by over 10% due to industry maturity, lower procurement prices, and improved self-manufacturing processes [1] - In Q2, the self-manufacturing ratio of tungsten wire mother lines reached 30%, expected to rise to around 50% by Q4 [1] - The shipment ratio of tungsten diamond wire in Q2 was nearly 55%, with July's shipment ratio reaching 85% [1] - The company benefits from a recycling advantage due to full-process production, with waste tungsten wire sourced from production scraps and customer-used waste lines [1] - Inventory impairment mainly occurred in the micro powder segment and due to auxiliary materials from process switching, with some potentially recoverable [1] - The procurement strategy focuses on demand-based purchasing to mitigate price fluctuation risks [1] Group 3 - Crystal Optoelectronics has developed a small quantity of laser radar window products for humanoid robots [2]